SmartLabs Announces Launch and Sell-Out of GxP-Compliant Animal Research and Manufacturing Facilities — MarketScreener

MarketScreener reported that SmartLabs’ newly completed GxP facilities in Boston were fully subscribed at launch, underscoring the market’s need for flexible, compliance-ready capacity. These environments support translational research, process development, and small-batch manufacturing for cell and gene therapy programs.

The sell-out reinforced the scalability of the Universal Lab Framework across both research and regulated operations.

Read the full article → MarketScreener